|
2014 |
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. |
Roberta Diaz Brinton, Ph.D |
|
2014 |
Environmental arsenic exposure and microbiota in induced sputum. |
|
|
2014 |
The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. |
|
|
2015 |
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Therapeutic potential of peroxynitrite decomposition catalysts: a patent review. |
Todd Vanderah, PhD |
|
2015 |
Perimenopause as a neurological transition state. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. |
|
|
2015 |
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia. |
Nam Lee, Ph.D. |
|
2015 |
Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6. |
|
|
2015 |
(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. |
|
|
2015 |
Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. |
Jeffrey J. Lochhead, PhD |
|
2015 |
Innovative qPCR using interfacial effects to enable low threshold cycle detection and inhibition relief. |
|
|
2015 |
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy. |
Nam Lee, Ph.D. |
|
2015 |
The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2015 |
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. |
|
|
2015 |
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. |
Frank Porreca, PhD |
|
2015 |
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Use of Animal Models in Understanding Cancer-induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. |
Patrick W Mantyh |
|
2015 |
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |
